nucynta
Takeover hostilities resume between Depomed and Horizon
August 10, 2015Sales and Marketing Depomed, horizon, hostile bid, nucynta, takeover, tapentadol
The bitter takeover row between Horizon and Depomed has escalated after Depomed dismissed its suitor’s latest advances, and warned it …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
